Wells Fargo & Company Zoetis Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Zoetis Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 6,273,433 shares of ZTS stock, worth $1.11 Billion. This represents 0.28% of its overall portfolio holdings.

Number of Shares

6,273,433

Previous 6,509,737 3.63%

Holding current value

$1.11 Billion

Previous $1.13 Billion 8.61%

% of portfolio

0.28%

Previous 0.28%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$172.58 - $196.48 $40.8 Million - $46.4 Million	-236,304 Reduced 3.63%	6,273,433 $1.23 Billion
Q2 2024 Aug 13, 2024	BUY	$145.54 - $178.83 $64.7 Million - $79.5 Million	444,835 Added 7.33%	6,509,737 $1.13 Billion
Q1 2024 May 10, 2024	BUY	$165.67 - $199.94 $575 Million - $694 Million	3,468,930 Added 133.63%	6,064,902 $1.03 Billion
Q4 2023 Feb 09, 2024	BUY	$151.44 - $200.09 $4.53 Million - $5.99 Million	29,923 Added 1.17%	2,595,972 $512 Million
Q3 2023 Nov 13, 2023	SELL	$167.14 - $192.77 $3.69 Million - $4.25 Million	-22,071 Reduced 0.85%	2,566,049 $446 Million
Q2 2023 Aug 15, 2023	BUY	$160.94 - $186.23 $20.4 Million - $23.6 Million	126,505 Added 5.14%	2,588,120 $446 Million
Q1 2023 May 12, 2023	BUY	$145.48 - $175.02 $27.6 Million - $33.2 Million	189,835 Added 8.36%	2,461,615 $410 Million
Q4 2022 Feb 13, 2023	BUY	$131.14 - $157.47 $24 Million - $28.9 Million	183,372 Added 8.78%	2,271,780 $333 Million
Q3 2022 Nov 14, 2022	SELL	$148.29 - $182.55 $10.7 Million - $13.2 Million	-72,147 Reduced 3.34%	2,088,408 $310 Million
Q2 2022 Aug 12, 2022	SELL	$155.97 - $200.09 $36.1 Million - $46.3 Million	-231,432 Reduced 9.68%	2,160,555 $371 Million
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $5.65 Million - $7.29 Million	-31,141 Reduced 1.29%	2,391,987 $451 Million
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $166 Million - $212 Million	-859,557 Reduced 26.18%	2,423,128 $591 Million
Q3 2021 Nov 15, 2021	SELL	$189.29 - $209.69 $58 Million - $64.2 Million	-306,178 Reduced 8.53%	3,282,685 $637 Million
Q2 2021 Aug 16, 2021	SELL	$155.9 - $187.99 $45.9 Million - $55.3 Million	-294,422 Reduced 7.58%	3,588,863 $669 Million
Q1 2021 May 13, 2021	SELL	$144.0 - $169.39 $40.3 Million - $47.4 Million	-279,763 Reduced 6.72%	3,883,285 $612 Million
Q4 2020 Feb 09, 2021	BUY	$157.07 - $174.35 $31.3 Million - $34.7 Million	199,155 Added 5.02%	4,163,048 $689 Million
Q3 2020 Nov 05, 2020	SELL	$137.1 - $165.37 $678,507 - $818,416	-4,949 Reduced 0.12%	3,963,893 $656 Million
Q2 2020 Aug 13, 2020	SELL	$111.92 - $142.53 $27.2 Million - $34.7 Million	-243,130 Reduced 5.77%	3,968,842 $544 Million
Q1 2020 May 14, 2020	BUY	$92.66 - $144.94 $390 Million - $610 Million	4,211,972 New	4,211,972 $496 Million

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

412M

Call Options Held

1.02M

Put Options Held

1.09M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.8B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Zoetis Inc. Transaction History